Sep. 26 at 12:19 AM
$MRT Litchfield Hills is out with a new report on
$MRT. This part stands out:
"If we compare MRT to companies with a more similar growth profile, the shares are valued significantly below average. If it were to trade at
$7, its 2026 Market Cap/Sales multiple would be ~4.5x, which would still be below average. This broadly confirms our view that, along with our discounted earnings model, the shares are undervalued."